Please assess the completion status of the following clinical trial:

Trial Title: Persistence of Oral Tolerance to Peanut

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* All LEAP Study participants who are evaluable for peanut allergy at year 5 by LEAP (ClinicalTrials.gov ID NCT00329784) Study criteria.~* Parent or guardian willing to provide informed consent.~Exclusion Criteria:~* Unable or unwilling to comply with study intervention and procedures.~* Participation in other food allergy intervention trials.

- Gender: ALL
- Minimum Age: 5 Years
- Maximum Age: 5 Years
- Healthy Volunteers: f

Study Arms:
- Peanut avoidance after continuous peanut consumption (Type: EXPERIMENTAL): These participants were the peanut consumption group of the ITN032AD (LEAP) study
- Continued peanut avoidance (Type: EXPERIMENTAL): These participants were the peanut avoidance group of the ITN032AD (LEAP) study

Based on this trial design, predict the completion outcome and termination type (if applicable).